Menarini Group Seeks $80 Million Worth Of Brazil Drug Brands
This article was originally published in PharmAsia News
Executive Summary
A few Brazil drug makers are said to be in discussions to sell some of their brands of cardiovascular , gastroenterology and pain drugs to Menarini India, an arm of Italy's drug giant Menarini Goup.